User login
The author reports no financial relationships relevant to this article.
OBs get codes for unremarkable sonograms ordered on the basis of suspicion. For gyn practice, options expand for abnormal Pap smear results. Here are the details.
Revisions and additions to the International Classification of Diseases, Clinical Modification (ICD-9-CM) for 2009, which take effect on October 1, 2008, bring especially good news to obstetricians who are testing for “conditions not found,” evaluating or treating twin-to-twin transfusion syndrome, dealing with the aftermath of maternal surgery, and providing the correct diagnostic code match for screening tests.
Gyn practitioners, don’t feel slighted: Many new codes take effect on that October day, covering abnormal Pap smear results, prophylactic drug treatment, breast conditions, and taking a patient’s personal history.
Remember: 1) October 1 is the key date here—when all the new and revised codes described in this article (and others not reviewed here) are added to the national code set, and 2) as in past years, there will be no grace period!
New and revised OB codes
FOR “CONDITIONS NOT FOUND”
How many times have you ordered a sonogram for a suspected problem with a pregnancy, only to have the scan reveal that all is normal? You then had to use either 1) a screening code for the condition or 2) an unspecified code because you could not assign a code that gave a condition to the patient that she did not have.
With addition of a new category of codes (V89), this obstetrical problem will be solved.
V89.01 Suspected problem with amniotic cavity and membrane not found
V89.02 Suspected placenta not found
V89.03 Suspected fetal anomaly not found
V89.04 Suspected problem with fetal growth not found
V89.05 Suspected cervical shortening not found
V89.09 Other suspected maternal and fetal condition not found
CERVICAL SHORTENING
Women undergo cervical shortening normally as their body prepares for labor, of course, but, on occasion, cervical shortening can indicate impending premature birth. Until now, you might have reflected this condition with 654.5x (Cervical incompetence complicating pregnancy), 654.6x (Other congenital or acquired abnormality of cervix), or 644.1x (Other threatened labor). Starting October 1, however, you’ll have a more precise code available to report this condition: 649.7x (Cervical shortening).
HIGH-RISK PREGNANCY
The V23 category of codes, which represent supervision of high-risk pregnancy, becomes more specific with two additions: V23.85 (Pregnancy resulting from assisted reproductive technology) and V23.86 (Pregnancy with history of in utero procedure during previous pregnancy).
ANTENATAL SCREENING
How to select the right code to report a screening test has been less than clear. Were you performing it to screen for malformation of a fetus? Some other reason? Three new antenatal codes and revision of an existing code (V28.3) clarify the distinction.
V28.3 Encounter for routine screening for malformation using ultrasonics
V28.81 Encounter for fetal anatomic survey
V28.82 Encounter for screening for risk of preterm labor
V28.89 Other specified antenatal screening
ICD-9-CM now directs that the latter code, V28.89, be reported for screening as part of chorionic villus sampling, nuchal translucency testing, genomic screening, and proteomic screening.
COMPLICATIONS OF PREGNANCY AND IN UTERO PROCEDURES
At last, you have a specific code for fetal conjoined twins (678.1x) and one for such fetal hematologic conditions as fetal anemia, thrombocytopenia, and twin-to-twin transfusion syndrome (678.0x).
In addition, complications from an in utero procedure will have two new codes: 679.0x (Maternal complications from in utero procedure) and 679.1x (Fetal complications from in utero procedure).
Gynecologic code changes and additions
ABNORMAL RESULTS OF A PAP SMEAR
You already know to look at the 795 series for ICD-9 codes to support various abnormal Pap smear results; after October 1, you’ll have a lot of new options.
Key developments:
- The risk of dysplasia and carcinoma is the same for the anus as it is for the cervix, so physicians can take anal cytologic smears.
- The cervix and the anus both have transformation zones where mucosa turns from squamous to columnar, so parallel codes have been created for anal smears.
The new codes are listed below.
CERVIX
795.07 Satisfactory cervical smear but lacking transformation zone
VAGINA AND VULVA
795.10 Abnormal Papanicolaou smear of vagina
795.11 Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US)
795.12 Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)
795.13 Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL)
795.14 Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL)
795.15 Vaginal high risk papillomavirus (HPV) DNA test positive
795.16 Papanicolaou smear of vagina with cytologic evidence of malignancy
795.18 Unsatisfactory cytology smear
795.19 Other abnormal smear of vagina and vaginal HPV
ANUS
796.70 Abnormal glandular Papanicolaou smear of anus
796.71 Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US)
796.72 Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)
796.73 Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL)
796.74 Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL)
796.75 Anal high risk human papillomavirus (HPV) DNA test positive
796.76 Papanicolaou smear of anus with cytologic evidence of malignancy
796.77 Satisfactory anal smear but lacking transformation zone
796.78 Unsatisfactory anal cytology smear
796.79 Other abnormal Papanicolaou smear of anus and anal HPV
There is also a new code, 569.44 (Dysplasia of anus), to report anal dysplasia. In the past, this condition was reported using 569.49 (Other specified disorders of rectum and anus).
ACQUIRED ABSENCE CODES
Until now, only V45.77 (Acquired absence of genital organs) could be used to report this patient status. As of October 1, you’ll have to be more specific about what is absent, using any of the following three new codes. You might find these codes helpful in supporting the performance of screening Pap smears:
V88.01 Acquired absence of both cervix and uterus
V88.02 Acquired absence of uterus with remaining cervical stump
V88.03 Acquired absence of cervix with remaining uterus
These new codes can be reported in conjunction with V67.01 (Follow-up vaginal Pap smear) and V76.47 (Special screening for malignant neoplasm of vagina).
URINARY PROBLEMS
Use these three new codes to report various presentations of hematuria:
599.70 Hematuria, unspecified
599.71 Gross hematuria
599.72 Microscopic hematuria
Note: The old code for hematuria (599.7) did not require a fifth digit; after October 1, using that old code will trigger a denial of your claim.
In addition, you have two new codes with which to report urinary symptoms:
788.91 Functional urinary incontinence
788.99 Other symptoms involving urinary symptoms
VULVODYNIA AND VULVAR VESTIBULITIS
A single code (625.8) has been available to describe vulvodynia, and it was grouped into a general category that covered symptoms. This condition has been given three new codes.
625.70 Vulvodynia, unspecified
625.71 Vulvar vestibulitis
625.79 Other vulvodynia
BREAST DISORDERS
New codes for breast conditions are about to take effect. These include ptosis (611.81), hypoplasia (611.82), and other disorders of the breast, such as capsular contracture of a breast implant (611.89).
For surgeons who handle follow-up after breast surgery, two new codes describe problems with the reconstructed breast: 612.0 (Deformity of reconstructed breast) and 612.1 (Disproportion of reconstructed breast).
WOUND DISRUPTION
Under current ICD-9-CM guidelines, you must specify “external wound” or “internal wound” to code correctly for dehiscence. On October 1, you have the option to report an unspecified code, 998.30 (Disruption of wound, unspecified) if the record does not specify the type of wound.
PROPHYLACTIC USE OF AGENTS AFFECTING ESTROGEN RECEPTORS AND ESTROGEN LEVELS
ICD-9-CM created a V code to capture data on the many women who receive tamoxifen and raloxifene after treatment of breast cancer. This code has been expanded to include V codes for different classes of drugs used for this type of therapy:
V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs)
V07.52 Prophylactic use of aromatase inhibitors
V07.59 Prophylactic use of agents affecting estrogen receptors and estrogen levels
From a guideline perspective, you can use the cancer code with one of these codes throughout the course of treatment, including during routine chemotherapy and radiation therapy. Long-term use of a drug that falls under the V07.5x category doesn’t require continued use of the cancer code, however.
You can provide additional information on your patient by reporting her estrogen receptor-positive status (V86.0), personal or family history of breast cancer (V10.3/V16.3), genetic susceptibility to cancer (V84.01–V84.09), and postmenopausal status (V49.81).
TAKING A PERSONAL HISTORY
This year, 11 codes make their debut to allow you to report a patient’s personal history. Use them for encounters in which the personal history has a direct impact on the patient’s complaints or status.
V13.51 Personal history of pathologic fracture
V13.52 Personal history of stress fracture
V13.59 Personal history of other musculoskeletal disorders
V15.51 Personal history of traumatic fracture
V15.59 Personal history of other injury
V15.21 Personal history of undergoing in utero procedure during pregnancy
V15.22 Personal history of undergoing in utero procedure while a fetus
V15.29 Personal history of surgery to other organs
V87.41 Personal history of antineoplastic chemotherapy
V87.42 Personal history of monoclonal drug therapy
V87.49 Personal history of other drug therapy
The author reports no financial relationships relevant to this article.
OBs get codes for unremarkable sonograms ordered on the basis of suspicion. For gyn practice, options expand for abnormal Pap smear results. Here are the details.
Revisions and additions to the International Classification of Diseases, Clinical Modification (ICD-9-CM) for 2009, which take effect on October 1, 2008, bring especially good news to obstetricians who are testing for “conditions not found,” evaluating or treating twin-to-twin transfusion syndrome, dealing with the aftermath of maternal surgery, and providing the correct diagnostic code match for screening tests.
Gyn practitioners, don’t feel slighted: Many new codes take effect on that October day, covering abnormal Pap smear results, prophylactic drug treatment, breast conditions, and taking a patient’s personal history.
Remember: 1) October 1 is the key date here—when all the new and revised codes described in this article (and others not reviewed here) are added to the national code set, and 2) as in past years, there will be no grace period!
New and revised OB codes
FOR “CONDITIONS NOT FOUND”
How many times have you ordered a sonogram for a suspected problem with a pregnancy, only to have the scan reveal that all is normal? You then had to use either 1) a screening code for the condition or 2) an unspecified code because you could not assign a code that gave a condition to the patient that she did not have.
With addition of a new category of codes (V89), this obstetrical problem will be solved.
V89.01 Suspected problem with amniotic cavity and membrane not found
V89.02 Suspected placenta not found
V89.03 Suspected fetal anomaly not found
V89.04 Suspected problem with fetal growth not found
V89.05 Suspected cervical shortening not found
V89.09 Other suspected maternal and fetal condition not found
CERVICAL SHORTENING
Women undergo cervical shortening normally as their body prepares for labor, of course, but, on occasion, cervical shortening can indicate impending premature birth. Until now, you might have reflected this condition with 654.5x (Cervical incompetence complicating pregnancy), 654.6x (Other congenital or acquired abnormality of cervix), or 644.1x (Other threatened labor). Starting October 1, however, you’ll have a more precise code available to report this condition: 649.7x (Cervical shortening).
HIGH-RISK PREGNANCY
The V23 category of codes, which represent supervision of high-risk pregnancy, becomes more specific with two additions: V23.85 (Pregnancy resulting from assisted reproductive technology) and V23.86 (Pregnancy with history of in utero procedure during previous pregnancy).
ANTENATAL SCREENING
How to select the right code to report a screening test has been less than clear. Were you performing it to screen for malformation of a fetus? Some other reason? Three new antenatal codes and revision of an existing code (V28.3) clarify the distinction.
V28.3 Encounter for routine screening for malformation using ultrasonics
V28.81 Encounter for fetal anatomic survey
V28.82 Encounter for screening for risk of preterm labor
V28.89 Other specified antenatal screening
ICD-9-CM now directs that the latter code, V28.89, be reported for screening as part of chorionic villus sampling, nuchal translucency testing, genomic screening, and proteomic screening.
COMPLICATIONS OF PREGNANCY AND IN UTERO PROCEDURES
At last, you have a specific code for fetal conjoined twins (678.1x) and one for such fetal hematologic conditions as fetal anemia, thrombocytopenia, and twin-to-twin transfusion syndrome (678.0x).
In addition, complications from an in utero procedure will have two new codes: 679.0x (Maternal complications from in utero procedure) and 679.1x (Fetal complications from in utero procedure).
Gynecologic code changes and additions
ABNORMAL RESULTS OF A PAP SMEAR
You already know to look at the 795 series for ICD-9 codes to support various abnormal Pap smear results; after October 1, you’ll have a lot of new options.
Key developments:
- The risk of dysplasia and carcinoma is the same for the anus as it is for the cervix, so physicians can take anal cytologic smears.
- The cervix and the anus both have transformation zones where mucosa turns from squamous to columnar, so parallel codes have been created for anal smears.
The new codes are listed below.
CERVIX
795.07 Satisfactory cervical smear but lacking transformation zone
VAGINA AND VULVA
795.10 Abnormal Papanicolaou smear of vagina
795.11 Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US)
795.12 Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)
795.13 Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL)
795.14 Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL)
795.15 Vaginal high risk papillomavirus (HPV) DNA test positive
795.16 Papanicolaou smear of vagina with cytologic evidence of malignancy
795.18 Unsatisfactory cytology smear
795.19 Other abnormal smear of vagina and vaginal HPV
ANUS
796.70 Abnormal glandular Papanicolaou smear of anus
796.71 Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US)
796.72 Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)
796.73 Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL)
796.74 Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL)
796.75 Anal high risk human papillomavirus (HPV) DNA test positive
796.76 Papanicolaou smear of anus with cytologic evidence of malignancy
796.77 Satisfactory anal smear but lacking transformation zone
796.78 Unsatisfactory anal cytology smear
796.79 Other abnormal Papanicolaou smear of anus and anal HPV
There is also a new code, 569.44 (Dysplasia of anus), to report anal dysplasia. In the past, this condition was reported using 569.49 (Other specified disorders of rectum and anus).
ACQUIRED ABSENCE CODES
Until now, only V45.77 (Acquired absence of genital organs) could be used to report this patient status. As of October 1, you’ll have to be more specific about what is absent, using any of the following three new codes. You might find these codes helpful in supporting the performance of screening Pap smears:
V88.01 Acquired absence of both cervix and uterus
V88.02 Acquired absence of uterus with remaining cervical stump
V88.03 Acquired absence of cervix with remaining uterus
These new codes can be reported in conjunction with V67.01 (Follow-up vaginal Pap smear) and V76.47 (Special screening for malignant neoplasm of vagina).
URINARY PROBLEMS
Use these three new codes to report various presentations of hematuria:
599.70 Hematuria, unspecified
599.71 Gross hematuria
599.72 Microscopic hematuria
Note: The old code for hematuria (599.7) did not require a fifth digit; after October 1, using that old code will trigger a denial of your claim.
In addition, you have two new codes with which to report urinary symptoms:
788.91 Functional urinary incontinence
788.99 Other symptoms involving urinary symptoms
VULVODYNIA AND VULVAR VESTIBULITIS
A single code (625.8) has been available to describe vulvodynia, and it was grouped into a general category that covered symptoms. This condition has been given three new codes.
625.70 Vulvodynia, unspecified
625.71 Vulvar vestibulitis
625.79 Other vulvodynia
BREAST DISORDERS
New codes for breast conditions are about to take effect. These include ptosis (611.81), hypoplasia (611.82), and other disorders of the breast, such as capsular contracture of a breast implant (611.89).
For surgeons who handle follow-up after breast surgery, two new codes describe problems with the reconstructed breast: 612.0 (Deformity of reconstructed breast) and 612.1 (Disproportion of reconstructed breast).
WOUND DISRUPTION
Under current ICD-9-CM guidelines, you must specify “external wound” or “internal wound” to code correctly for dehiscence. On October 1, you have the option to report an unspecified code, 998.30 (Disruption of wound, unspecified) if the record does not specify the type of wound.
PROPHYLACTIC USE OF AGENTS AFFECTING ESTROGEN RECEPTORS AND ESTROGEN LEVELS
ICD-9-CM created a V code to capture data on the many women who receive tamoxifen and raloxifene after treatment of breast cancer. This code has been expanded to include V codes for different classes of drugs used for this type of therapy:
V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs)
V07.52 Prophylactic use of aromatase inhibitors
V07.59 Prophylactic use of agents affecting estrogen receptors and estrogen levels
From a guideline perspective, you can use the cancer code with one of these codes throughout the course of treatment, including during routine chemotherapy and radiation therapy. Long-term use of a drug that falls under the V07.5x category doesn’t require continued use of the cancer code, however.
You can provide additional information on your patient by reporting her estrogen receptor-positive status (V86.0), personal or family history of breast cancer (V10.3/V16.3), genetic susceptibility to cancer (V84.01–V84.09), and postmenopausal status (V49.81).
TAKING A PERSONAL HISTORY
This year, 11 codes make their debut to allow you to report a patient’s personal history. Use them for encounters in which the personal history has a direct impact on the patient’s complaints or status.
V13.51 Personal history of pathologic fracture
V13.52 Personal history of stress fracture
V13.59 Personal history of other musculoskeletal disorders
V15.51 Personal history of traumatic fracture
V15.59 Personal history of other injury
V15.21 Personal history of undergoing in utero procedure during pregnancy
V15.22 Personal history of undergoing in utero procedure while a fetus
V15.29 Personal history of surgery to other organs
V87.41 Personal history of antineoplastic chemotherapy
V87.42 Personal history of monoclonal drug therapy
V87.49 Personal history of other drug therapy
The author reports no financial relationships relevant to this article.
OBs get codes for unremarkable sonograms ordered on the basis of suspicion. For gyn practice, options expand for abnormal Pap smear results. Here are the details.
Revisions and additions to the International Classification of Diseases, Clinical Modification (ICD-9-CM) for 2009, which take effect on October 1, 2008, bring especially good news to obstetricians who are testing for “conditions not found,” evaluating or treating twin-to-twin transfusion syndrome, dealing with the aftermath of maternal surgery, and providing the correct diagnostic code match for screening tests.
Gyn practitioners, don’t feel slighted: Many new codes take effect on that October day, covering abnormal Pap smear results, prophylactic drug treatment, breast conditions, and taking a patient’s personal history.
Remember: 1) October 1 is the key date here—when all the new and revised codes described in this article (and others not reviewed here) are added to the national code set, and 2) as in past years, there will be no grace period!
New and revised OB codes
FOR “CONDITIONS NOT FOUND”
How many times have you ordered a sonogram for a suspected problem with a pregnancy, only to have the scan reveal that all is normal? You then had to use either 1) a screening code for the condition or 2) an unspecified code because you could not assign a code that gave a condition to the patient that she did not have.
With addition of a new category of codes (V89), this obstetrical problem will be solved.
V89.01 Suspected problem with amniotic cavity and membrane not found
V89.02 Suspected placenta not found
V89.03 Suspected fetal anomaly not found
V89.04 Suspected problem with fetal growth not found
V89.05 Suspected cervical shortening not found
V89.09 Other suspected maternal and fetal condition not found
CERVICAL SHORTENING
Women undergo cervical shortening normally as their body prepares for labor, of course, but, on occasion, cervical shortening can indicate impending premature birth. Until now, you might have reflected this condition with 654.5x (Cervical incompetence complicating pregnancy), 654.6x (Other congenital or acquired abnormality of cervix), or 644.1x (Other threatened labor). Starting October 1, however, you’ll have a more precise code available to report this condition: 649.7x (Cervical shortening).
HIGH-RISK PREGNANCY
The V23 category of codes, which represent supervision of high-risk pregnancy, becomes more specific with two additions: V23.85 (Pregnancy resulting from assisted reproductive technology) and V23.86 (Pregnancy with history of in utero procedure during previous pregnancy).
ANTENATAL SCREENING
How to select the right code to report a screening test has been less than clear. Were you performing it to screen for malformation of a fetus? Some other reason? Three new antenatal codes and revision of an existing code (V28.3) clarify the distinction.
V28.3 Encounter for routine screening for malformation using ultrasonics
V28.81 Encounter for fetal anatomic survey
V28.82 Encounter for screening for risk of preterm labor
V28.89 Other specified antenatal screening
ICD-9-CM now directs that the latter code, V28.89, be reported for screening as part of chorionic villus sampling, nuchal translucency testing, genomic screening, and proteomic screening.
COMPLICATIONS OF PREGNANCY AND IN UTERO PROCEDURES
At last, you have a specific code for fetal conjoined twins (678.1x) and one for such fetal hematologic conditions as fetal anemia, thrombocytopenia, and twin-to-twin transfusion syndrome (678.0x).
In addition, complications from an in utero procedure will have two new codes: 679.0x (Maternal complications from in utero procedure) and 679.1x (Fetal complications from in utero procedure).
Gynecologic code changes and additions
ABNORMAL RESULTS OF A PAP SMEAR
You already know to look at the 795 series for ICD-9 codes to support various abnormal Pap smear results; after October 1, you’ll have a lot of new options.
Key developments:
- The risk of dysplasia and carcinoma is the same for the anus as it is for the cervix, so physicians can take anal cytologic smears.
- The cervix and the anus both have transformation zones where mucosa turns from squamous to columnar, so parallel codes have been created for anal smears.
The new codes are listed below.
CERVIX
795.07 Satisfactory cervical smear but lacking transformation zone
VAGINA AND VULVA
795.10 Abnormal Papanicolaou smear of vagina
795.11 Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US)
795.12 Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)
795.13 Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL)
795.14 Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL)
795.15 Vaginal high risk papillomavirus (HPV) DNA test positive
795.16 Papanicolaou smear of vagina with cytologic evidence of malignancy
795.18 Unsatisfactory cytology smear
795.19 Other abnormal smear of vagina and vaginal HPV
ANUS
796.70 Abnormal glandular Papanicolaou smear of anus
796.71 Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US)
796.72 Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)
796.73 Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL)
796.74 Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL)
796.75 Anal high risk human papillomavirus (HPV) DNA test positive
796.76 Papanicolaou smear of anus with cytologic evidence of malignancy
796.77 Satisfactory anal smear but lacking transformation zone
796.78 Unsatisfactory anal cytology smear
796.79 Other abnormal Papanicolaou smear of anus and anal HPV
There is also a new code, 569.44 (Dysplasia of anus), to report anal dysplasia. In the past, this condition was reported using 569.49 (Other specified disorders of rectum and anus).
ACQUIRED ABSENCE CODES
Until now, only V45.77 (Acquired absence of genital organs) could be used to report this patient status. As of October 1, you’ll have to be more specific about what is absent, using any of the following three new codes. You might find these codes helpful in supporting the performance of screening Pap smears:
V88.01 Acquired absence of both cervix and uterus
V88.02 Acquired absence of uterus with remaining cervical stump
V88.03 Acquired absence of cervix with remaining uterus
These new codes can be reported in conjunction with V67.01 (Follow-up vaginal Pap smear) and V76.47 (Special screening for malignant neoplasm of vagina).
URINARY PROBLEMS
Use these three new codes to report various presentations of hematuria:
599.70 Hematuria, unspecified
599.71 Gross hematuria
599.72 Microscopic hematuria
Note: The old code for hematuria (599.7) did not require a fifth digit; after October 1, using that old code will trigger a denial of your claim.
In addition, you have two new codes with which to report urinary symptoms:
788.91 Functional urinary incontinence
788.99 Other symptoms involving urinary symptoms
VULVODYNIA AND VULVAR VESTIBULITIS
A single code (625.8) has been available to describe vulvodynia, and it was grouped into a general category that covered symptoms. This condition has been given three new codes.
625.70 Vulvodynia, unspecified
625.71 Vulvar vestibulitis
625.79 Other vulvodynia
BREAST DISORDERS
New codes for breast conditions are about to take effect. These include ptosis (611.81), hypoplasia (611.82), and other disorders of the breast, such as capsular contracture of a breast implant (611.89).
For surgeons who handle follow-up after breast surgery, two new codes describe problems with the reconstructed breast: 612.0 (Deformity of reconstructed breast) and 612.1 (Disproportion of reconstructed breast).
WOUND DISRUPTION
Under current ICD-9-CM guidelines, you must specify “external wound” or “internal wound” to code correctly for dehiscence. On October 1, you have the option to report an unspecified code, 998.30 (Disruption of wound, unspecified) if the record does not specify the type of wound.
PROPHYLACTIC USE OF AGENTS AFFECTING ESTROGEN RECEPTORS AND ESTROGEN LEVELS
ICD-9-CM created a V code to capture data on the many women who receive tamoxifen and raloxifene after treatment of breast cancer. This code has been expanded to include V codes for different classes of drugs used for this type of therapy:
V07.51 Prophylactic use of selective estrogen receptor modulators (SERMs)
V07.52 Prophylactic use of aromatase inhibitors
V07.59 Prophylactic use of agents affecting estrogen receptors and estrogen levels
From a guideline perspective, you can use the cancer code with one of these codes throughout the course of treatment, including during routine chemotherapy and radiation therapy. Long-term use of a drug that falls under the V07.5x category doesn’t require continued use of the cancer code, however.
You can provide additional information on your patient by reporting her estrogen receptor-positive status (V86.0), personal or family history of breast cancer (V10.3/V16.3), genetic susceptibility to cancer (V84.01–V84.09), and postmenopausal status (V49.81).
TAKING A PERSONAL HISTORY
This year, 11 codes make their debut to allow you to report a patient’s personal history. Use them for encounters in which the personal history has a direct impact on the patient’s complaints or status.
V13.51 Personal history of pathologic fracture
V13.52 Personal history of stress fracture
V13.59 Personal history of other musculoskeletal disorders
V15.51 Personal history of traumatic fracture
V15.59 Personal history of other injury
V15.21 Personal history of undergoing in utero procedure during pregnancy
V15.22 Personal history of undergoing in utero procedure while a fetus
V15.29 Personal history of surgery to other organs
V87.41 Personal history of antineoplastic chemotherapy
V87.42 Personal history of monoclonal drug therapy
V87.49 Personal history of other drug therapy